What Blackbaud (BLKB) Said on Its Q3 Earnings Call

Blackbaud (BLKB) reported Q3 revenue of $293M, up 4.1%, with non-GAAP EPS of $1.36, up 24%. The company discussed AI product adoption, core platform investments, and long-term growth targets. 2026 guidance excludes AI revenue, but sees potential upside. 90% of recurring revenue is on 3+ year contracts.

Original reporting
Published Oct 28, 2026, 2:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 2:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What Blackbaud (BLKB) Said on Its Q3 Earnings Call — source image
Decision brief

The 30-second read

$BLKBNeutralMed
01

Why it matters

The earnings beat and cash generation support the stock, but the lack of AI revenue guidance may temper enthusiasm, creating a mixed short‑term outlook.

02

Market read

Primary earnings disclosure for a mid‑cap SaaS provider with actionable guidance and buyback details.

03

What to watch

Potential long‑term upside from AI product adoption and contract renewal cohort expansion.

Relevance 8/10Novelty 8/10Timing: post-earnings today

Background

Blackbaud's Q3 earnings call covered financial results, product updates, and guidance for 2026‑2027, including AI initiatives and share repurchase activity.

Company-level read

Ticker impact

$BLKBNeutralHigh confidence
Context

Blackbaud reported Q3 results with $293M revenue and provided 2026 guidance lacking AI product revenue, while announcing a share repurchase and new product rollouts.

Expected impact

likely slight downside pressure as guidance omits AI revenue contribution, offset by buyback support

Evidence & confidence

Guidance does not include meaningful AI revenue, which may disappoint investors, but the ongoing share repurchase and strong cash flow provide a floor.

Market effects

Signals slower near-term monetization of AI add‑ons in the nonprofit‑software sector.

Limited to U.S. listed software stocks; no broader regional effect.

Minimal global impact; primarily relevant to investors in Blackbaud and comparable SaaS firms.

Counterpoint

Buy on the strength of cash flow and ongoing buybacks despite muted AI guidance.

Key entities

  • Gianoni

    Executive discussing AI product rollout and product strategy.

  • Chad Anderson

    Provided financial commentary on revenue, guidance, and share repurchase.

Related articles

$BLKBMedAI 8/10

Blackbaud Inc (BLKB) (Q3 2026) Earnings Call Highlights: Strong Cash Flow, AI Innovation

Blackbaud Inc (BLKB) reported Q3 2026 revenue of $293M, up 4.1%, with adjusted EBITDA at $111M and free cash flow at $126M. The company faces near-term challenges including a larger renewal cohort affecting retention and transactional revenue variability. AI products are not expected to contribute meaningfully to revenue in 2026, with commercialization planned for 2027.

$BLKBMedAI 8/10

Blackbaud: Q3 Earnings Snapshot

Blackbaud Inc. (BLKB) reported Q3 net income of $46.1M, or $1.02 per share, with adjusted EPS of $1.36. Revenue was $292.6M. The company expects full-year EPS of $5.15-$5.25 and revenue of $1.17B-$1.18B. BLKB shares have fallen 19% YTD and 21% over the past year.

$BLKBMed

Blackbaud, Inc. Q3 2026 Earnings Call Summary

Blackbaud, Inc. is shifting its product portfolio to 'systems of intelligent action' with AI integration. Management expects Q3 2026 revenue and adjusted EBITDA to meet or exceed guidance, with long-term targets of 4-6% annual organic revenue growth and 40%+ EBITDA margins. The company plans to use 50% of free cash flow for stock repurchases through 2030. Blackbaud is also modernizing operations, closing data centers, and introducing a new platform fee.

$BLKBHighAI 8/10

Blackbaud Q3 2026 slides: profitability up 24%, shares fall on growth

Blackbaud (BLKB) reported Q3 2026 earnings with 4.1% organic revenue growth to $292.6M, beating EPS estimates but missing revenue forecasts. Shares fell 8.75% premarket. Profitability improved, with non-GAAP EBITDA up 11% and EPS up 24%. The company maintained full-year guidance, targeting 4.25% revenue growth. Investors focused on near-term growth concerns despite strong margins and cash flow.